🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested
This phase II trial is studying how well giving combination chemotherapy to...
Status
Completed
Location
SWOG
Start Date
2005-06
Trial ID
NCT00121199
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00933127
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
The goal of this clinical research study is to learn if radiation therapy a...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2011-05
Trial ID
NCT01321008
Treatments Being Tested
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nod...
Status
Terminated
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00893516
Treatments Being Tested
The purpose of this study is to clarify the impact of rituximab on clinical...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2011-08
Trial ID
NCT01448096
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Withdrawn
Location
Hoag Memorial Hospital Presbyterian
Start Date
1998-06
Trial ID
NCT00004039
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested